Surgical Automations, Inc.

Based in the US, Surgical Automations develops advanced medical technology, focusing on innovative robotic systems to enhance endoscopic procedures and improve patient care outcomes. Founded in 2023 in Dallas, US, Surgical Automations specializes in medical robotics with its flagship Vāsuki Robotic System. The company raised USD 3. 4 mn in Seed funding in February 2025, co-led by TurboStart and other investors, bringing total funding to USD 3.

4 mn. The firm has completed one deal to date. Surgical Automations specializes in developing advanced medical technology through its flagship Vāsuki Robotic System. This system integrates AI-guided automation and precision engineering to improve endoscopy procedures, aiding healthcare professionals in complex medical cases.

The Vāsuki system is targeted at surgeons and gastroenterologists in hospitals and specialized medical facilities, focusing on regions with robust healthcare infrastructures such as North America, Europe, and parts of Asia. Surgical Automations generates revenue primarily through sales of the Vāsuki Robotic System and associated services, structured via direct partnerships with healthcare providers. Revenue streams include upfront system costs and ongoing service agreements, which may cover maintenance and training for medical staff. The company is also considering subscription models for software enhancements to ensure ongoing client value as demand for innovative endoscopic solutions rises.

The company will use the October 2025 funding to advance the Vāsuki Robotic System through pre-clinical validation and first-in-human studies, focusing on automating critical steps in gastrointestinal endoscopy.